Texas Asks Court to Halt Kenvue Tylenol Marketing, Dividend (2)

Nov. 6, 2025, 10:47 PM UTC

Texas officials have asked a state court judge to temporarily block Kenvue Inc. from marketing Tylenol as safe for pregnant women, and from issuing a dividend, escalating the company’s legal woes just days after announcing a major merger with Kimberly-Clark Corp.

The request for a temporary restraining order is the latest step in Texas Attorney General Ken Paxton’s effort to hold the Tylenol maker and its former parent company, Johnson & Johnson, accountable for what he alleges was a years-long campaign to conceal links of acetaminophen — the active ingredient in Tylenol — to autism and other disorders for ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.